Work

Real-world outcomes with blinatumomab as a bridging therapy for allogeneic hematopoietic stem cell transplantation in relapsed/refractory or measurable residual disease-positive B-cell acute lymphoblastic leukemia: A CIBMTR database analysis

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-6044

Authors: Wael Saber, Ruta Brazauskas, Jinalben Patel, Mona Patel, Lori Muffly, Mark Juckett, Michael Grunwald, Nelli Bejanyan, Tania Jain, Veronika Bachanova, Heejoo Jo, Biyao Zou, Jessica Choudhry, Yi Zeng

Institutions: Medical College of Wisconsin, Stanford Health Care, Stanford Medicine, University of Minnesota, Levine Cancer Institute, Wake Forest University, Moffitt Cancer Center, Johns Hopkins University, Amgen (United States)

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417022498

Cites:

Cited by: 1

Related to: